Petros Pharmaceuticals Inc (PTPI)
0.58
+0.03
(+5.82%)
USD |
NASDAQ |
May 17, 16:00
0.58
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Cash from Operations (Quarterly): -2.260M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.260M |
| September 30, 2023 | -4.046M |
| June 30, 2023 | -0.5721M |
| March 31, 2023 | -0.7484M |
| December 31, 2022 | -1.570M |
| September 30, 2022 | -1.752M |
| June 30, 2022 | -4.200M |
| March 31, 2022 | -5.276M |
| December 31, 2021 | -8.304M |
| Date | Value |
|---|---|
| September 30, 2021 | -1.211M |
| June 30, 2021 | -1.900M |
| March 31, 2021 | -0.4466M |
| December 31, 2020 | -4.523M |
| September 30, 2020 | -2.667M |
| June 30, 2020 | -5.74M |
| March 31, 2020 | -2.375M |
| March 31, 2019 | 3.591B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.304M
Minimum
Dec 2021
-0.4466M
Maximum
Mar 2021
-2.974M
Average
-2.318M
Median
Cash from Operations (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -6.202M |
| Imunon Inc | -5.874M |
| iBio Inc | -4.706M |
| Ocugen Inc | -10.60M |
| Gritstone Bio Inc | -33.57M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -2.373M |
| Free Cash Flow | -7.626M |
| Free Cash Flow Per Share (Quarterly) | -0.9504 |
| Free Cash Flow to Equity (Quarterly) | -1.886M |
| Free Cash Flow to Firm (Quarterly) | -2.260M |
| Free Cash Flow Yield | -598.1% |